Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
금요일, 8월 28

US Physical Therapy Inc

USPHNYSE
Trade with Public
Trade with Public
$78.89
-0.21-0.27%
마지막 업데이트: Aug 28, 12:43 PM
배당금: 배당락일은 7일 전이었습니다
개요뉴스실적 전망이벤트목표가재무심리지분 현황배당금비교옵션주식 보고서

US Physical Therapy Analyst Price Targets

Wall Street analyst price targets and consensus rating for US Physical Therapy (USPH).

Price Target Range — 13 Quarters

Analyst Consensus — 7 Analysts

3S.Buy
4Buy
Consensus RatingBuy# Analysts7Avg. Consensus PT$105Upside to Avg. PT+33.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 10, 2026Barrington ResearchMichael PetuskyPT RaiseOutperform$90→$98
Jun 24, 2026CitizensConstantine DavidesMaintainedMarket Outperform$98
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Barrington Research Maintains Outperform on US Physical Therapy, Raises Price Target to $98

Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and raises the price target from $90 to $98.
Benzinga Newsdesk

PRO
Citizens Reiterates Market Outperform on US Physical Therapy, Maintains $98 Price Target

Citizens analyst Constantine Davides reiterates US Physical Therapy (NYSE:USPH) with a Market Outperform and maintains $98 price target.
Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on US Physical Therapy, Lowers Price Target to $90

Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and lowers the price target from $103 to $90.
Benzinga Newsdesk

PRO
Citizens Maintains Market Outperform on US Physical Therapy, Lowers Price Target to $98

Citizens analyst Constantine Davides maintains US Physical Therapy (NYSE:USPH) with a Market Outperform and lowers the price target from $113 to $98.
Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on US Physical Therapy, Maintains $103 Price Target

Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and maintains $103 price target.
Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on US Physical Therapy, Maintains $103 Price Target

Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and maintains $103 price target.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved